Equity Profile

STE

STERIS plc

Health CareHealth Care Equipment$21.2B

Aug5Wed

Pre-Earnings Brief

UpcomingQ1-2027After Close5:00 PM EDT

Company Snapshot

STERIS plc is a leading provider of health care equipment and services, focusing on sterilization and infection prevention solutions. As a key player in the health care sector, its products are essential for maintaining safety and efficiency in medical environments.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a critical measure of the company's profitability and will indicate how well STERIS is managing costs and generating revenue.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market presence and meet demand in the health care sector.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

STE Q1-2027 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+1.57%

Avg Stock Reaction

-0.34%

Last Quarter Recap

In the last quarter, STERIS reported an EPS of $2.83, slightly missing estimates. The stock reacted negatively, declining by 2.70% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations for STERIS's upcoming earnings are mixed, with no analyst estimates available. Investors are looking for signs of recovery after recent performance.

Bull Case

If STERIS can beat EPS expectations and show strong revenue growth, it may signal a rebound in demand for its products, boosting investor confidence.

Bear Case

Conversely, if the company fails to meet expectations again, it could raise concerns about its market position and growth potential, leading to further declines.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be this quarter, and how does it compare to previous quarters?

Given the recent trend of mixed earnings surprises, the EPS figure will be crucial in determining investor sentiment.

How is STERIS addressing current market challenges and competition?

Understanding the company's strategy in a competitive environment will help gauge its future growth potential.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating STERIS's ability to recover from recent challenges, as its strong product pipeline could drive unexpected growth.

Supporting Evidence

The recent EPS surprise rate of 75% indicates potential for positive surprises.

Options pricing suggests a larger move than historical averages, indicating heightened expectations.

Insider buying activity suggests confidence in the company's future performance.

Key Risk

If STERIS shows significant revenue growth, it could challenge the current cautious sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is currently uncertain about STERIS's ability to navigate recent challenges, making this earnings report critical.

Bull Confirmed If

A positive EPS surprise of over 3% would confirm a strong recovery narrative.

Bear Confirmed If

An EPS miss of more than 1% would indicate ongoing challenges and could lead to further stock declines.

Pre-Earnings Positioning

Options Market

Implied Move

±11.87%

Historical Avg

±1.0%

Pricing rich

The options market is pricing in a significant move, suggesting that investors expect volatility around the earnings report.

Options are pricing ±11.9% while STE has averaged ±1.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

28.7%

Calls (500)P/C Ratio: 11.00Puts (0)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing rich setup in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 3.7%, with a raw directional average of -1.4% (modestly negative historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If STERIS beats expectations, history suggests the stock could see a modest increase, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may remain stable, but cautious commentary could lead to volatility.

Miss

A miss could lead to a decline, with history suggesting an average drop of around 0.85% following such outcomes.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

3 buys·0 sells

Members

House only

Est. Notional

$3,003.00–$45,000.00

disclosed dollar ranges

Most Active Members

D-MDApril McClain DelaneyRep.
2

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's outlook on market conditions and competitive landscape.
3Details on cost management strategies and their effectiveness.
4Insights into customer demand trends and order backlog.
5Any commentary on regulatory changes affecting the health care equipment sector.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a critical measure of the company's profitability and will indicate how well STERIS is managing costs and generating revenue.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market presence and meet demand in the health care sector.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

STE Q1-2027 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+1.57%

Avg Stock Reaction

-0.34%

Last Quarter Recap

In the last quarter, STERIS reported an EPS of $2.83, slightly missing estimates. The stock reacted negatively, declining by 2.70% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations for STERIS's upcoming earnings are mixed, with no analyst estimates available. Investors are looking for signs of recovery after recent performance.

Bull Case

If STERIS can beat EPS expectations and show strong revenue growth, it may signal a rebound in demand for its products, boosting investor confidence.

Bear Case

Conversely, if the company fails to meet expectations again, it could raise concerns about its market position and growth potential, leading to further declines.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be this quarter, and how does it compare to previous quarters?

Given the recent trend of mixed earnings surprises, the EPS figure will be crucial in determining investor sentiment.

How is STERIS addressing current market challenges and competition?

Understanding the company's strategy in a competitive environment will help gauge its future growth potential.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating STERIS's ability to recover from recent challenges, as its strong product pipeline could drive unexpected growth.

Supporting Evidence

The recent EPS surprise rate of 75% indicates potential for positive surprises.

Options pricing suggests a larger move than historical averages, indicating heightened expectations.

Insider buying activity suggests confidence in the company's future performance.

Key Risk

If STERIS shows significant revenue growth, it could challenge the current cautious sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is currently uncertain about STERIS's ability to navigate recent challenges, making this earnings report critical.

Bull Confirmed If

A positive EPS surprise of over 3% would confirm a strong recovery narrative.

Bear Confirmed If

An EPS miss of more than 1% would indicate ongoing challenges and could lead to further stock declines.

Pre-Earnings Positioning

Options Market

Implied Move

±11.87%

Historical Avg

±1.0%

Pricing rich

The options market is pricing in a significant move, suggesting that investors expect volatility around the earnings report.

Options are pricing ±11.9% while STE has averaged ±1.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

28.7%

Calls (500)P/C Ratio: 11.00Puts (0)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing rich setup in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If STERIS beats expectations, history suggests the stock could see a modest increase, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may remain stable, but cautious commentary could lead to volatility.

Miss

A miss could lead to a decline, with history suggesting an average drop of around 0.85% following such outcomes.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

3 buys·0 sells

Members

House only

Est. Notional

$3,003.00–$45,000.00

disclosed dollar ranges

Most Active Members

D-MDApril McClain DelaneyRep.
2

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's outlook on market conditions and competitive landscape.
3Details on cost management strategies and their effectiveness.
4Insights into customer demand trends and order backlog.
5Any commentary on regulatory changes affecting the health care equipment sector.